" class="no-js "lang="en-US"> Novavax to Participate in Fireside Chat at Goldman Sachs Virtual Conference - Medtech Alert
Wednesday, March 29, 2023

Novavax to Participate in Fireside Chat at Goldman Sachs Virtual Conference

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will participate in a fireside chat during the Goldman Sachs Recovery Inoculated: The Current Outlook for COVID-19 Vaccines, Treatments, Testing and the Economy virtual conference. Novavax’ COVID-19 vaccine candidate, NVX-CoV2373, will be a topic of discussion.

Fireside chat details:
Date: Tuesday, April 13, 2021
Time: 2:30 – 3:20 p.m. Eastern Time (ET)
Panel title: COVID-19 Vaccines – Staying Ahead of the Curve
Novavax participant: Vivek Shinde, M.D., M.P.H., Vice President, Clinical Development
This event is open to Goldman Sachs clients.

Companies In This Post

  1. Coeptis Therapeutics Secures Exclusive Rights to Negotiate the Acquisition of Transformational Cell Therapy Platform Read more
  2. SamaCare Partners with AmerisourceBergen to Offer Prior Authorization Platform to Specialty Practices Read more
  3. Lucy Therapeutics Appoints Neuroscience Drug Discovery and Development Expert Christopher J. Winrow, Ph.D., as Chief Scientific Officer Read more
  4. BGI Genomics Partners with Zentya to Launch Fecal DNA Test for Colorectal Cancer in Slovakia Read more
  5. PharmaVentures Establishes an Office in Seoul to Enhance Access for South Korean Biotechs Read more